Variable contribution of the MTHFR C677T polymorphism to non-syndromic cleft lip and palate risk in China

JiangHui Zhu1, AiGuo Ren, Ling Hao

  • 1Institute of Reproductive Health, Peking University Health Science Center, Beijing, China. zhujh@ncmih.bjmu.edu.cn

Insights

Methylenetetrahydrofolate reductase (MTHFR) gene polymorphism is a risk factor for non-syndromic cleft lip/palate in Northern China. This genetic factor was not significantly associated in Southern Chinese populations, suggesting regional differences.

Area of Science:

  • Genetics
  • Developmental Biology
  • Public Health

Background:

  • Non-syndromic cleft lip with or without cleft palate (nsCL/P) is a common birth defect.
  • Folic acid supplementation may reduce nsCL/P, but the mechanism is unclear.
  • Regional variations in nsCL/P occurrence and risk factors are observed.

Purpose of the Study:

  • To investigate the association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and nsCL/P.
  • To explore potential genetic heterogeneity in nsCL/P between Northern and Southern Chinese populations.

Main Methods:

  • A case-parent triad study involving 170 Chinese families.
  • Genotyping of the MTHFR C677T polymorphism.
  • Statistical analysis of allele transmission and association with nsCL/P.

Main Results:

  • A moderate association was found between MTHFR C677T polymorphism and nsCL/P in Northern China.
  • This association was not significant in Southern China.
  • Heterozygous parents in the North were twice as likely to transmit the high-risk T allele to affected offspring compared to the South (OR = 2.24).

Conclusions:

  • MTHFR C677T polymorphism is a significant risk factor for nsCL/P in Northern China.
  • Genetic heterogeneity in nsCL/P development may exist between Northern and Southern Chinese populations.
  • Further research is needed to elucidate the underlying mechanisms.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...